FOCUS- Abbott to hike production of lower-cost glucose monitors as diabetes soars
Abbott Laboratories
plans to ramp up manufacturing capacity for its lower-cost
continuous glucose monitor, the FreeStyle Libre, by three to
five times in the next few years, aiming to reach millions more
patients worldwide, the company told Reuters.
plans to ramp up manufacturing capacity for its lower-cost
continuous glucose monitor, the FreeStyle Libre, by three to
five times in the next few years, aiming to reach millions more
patients worldwide, the company told Reuters.
Posted by Reuters
